PrismML's Bonsai 27B runs full reasoning AI on an iPhone for free. We tested it, and considering the tradeoffs, the results ...

Some, however, find that bridging fields opens new realms of possibility. Henry Kvinge, who trained as a mathematician but ...

Kevin Lieber of Vsauce2 explores how researchers apply complex mathematics to transform Pi into Phi. Social Security's 2027 COLA forecast was just updated. There's bad news and good news for retirees.

Tiny, quivering spheres designed to feed and multiply raise prospect of artificial organisms to make drugs, food and fuel Researchers claim they are closer to creating life from scratch after building ...

Lawrence Berkeley National Laboratory estimated the facilities could use roughly 11.8 percent of U.S. power by the end of the decade. Data centers could more than double their share of U.S. power and ...

Hey, everyone! SpaceX just did a successful test for their Starship-28 rocket, which is part of their plan to launch their third Starship soon. They are also going to test their Super Heavy booster-10 ...

Project Valhalla’s value classes are heading to JDK 28, a 197,000-line change that rewrites how Java handles object identity. Oracle software engineer Lois Foltan has confirmed that Java Enhancement ...

IPO mania has begun, and nothing kickstarts initial public offerings like spreadsheets flashing green to incite the crowd. SpaceX’s recent S-1 filing promoted an “actionable total addressable market” ...

Jefferson Lab’s new operators said it’s business as usual with a new contract that ends a more than year-long procurement process that threw the research facility’s future into uncertainty. At least ...

SANTA CRUZ — After 28 years of operation, the Java Junction location on River Street will close Monday, owner Michael Spadafora confirmed to the Sentinel. The coffee shop has been struggling since ...

Not too long ago I would have said I was one of the least likely people to be tempted by GLP-1s like Wegovy or Zepbound. My weight has always been average. I have no medical conditions, and more than ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and obesity. GLP-1 receptor ...